Lisata Therapeutics files prospectus for resale of up to 350,498,987 common shares
LSTA•Lisata Therapeutics filed a prospectus for the resale of up to 350,498,987 common shares by selling stockholders, according to a SEC filing.
1. Resale prospectus
Lisata Therapeutics filed a prospectus for the resale of up to 350,498,987 common shares by selling stockholders, a SEC filing showed.
